CMX-02

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameCMX-02
Drug Alias NameCMX-02
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionAnti-Interleukin-23Anti-Tumor necrosis factor α
TargetsTumor necrosis factor αInterleukin-23
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesComplix NVSelexis SA
China Registration ClassN/A

Develop Information

Active CompaniesComplix NVSelexis SA
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A